Dr Özdemir ist a physician scientist who has been a clinician since 2013. She completed her training as a medical oncologist in 2018 and focusses on precision oncology and immunotherapy. She studies the impact of sex and gender on cancer risk and patient outcome and is interested in developing sex-dependent dosing of treatment schemes and cancer prevention approaches.
